Business Context and Reporting Period
Company: Kimberly-Clark Corporation (KMB)
Filing Type: Form 8-K (Current Report)
Date of Report: December 4, 2025
Subject: Recasting of financial information in the 2024 Form 10-K to reflect the International Family Care and Professional (IFP) Business as discontinued operations.
Key Financial Metrics and Transaction Details
This filing does not present new period-over-period financial performance metrics (revenue, profit, cash flow) for the current quarter. Instead, it details a specific transaction driving the recast:
- Transaction: Formation of a joint venture with Suzano S.A. comprising substantially all operations of the former IFP segment.
- Ownership Structure: Suzano acquires a 51% interest; Kimberly-Clark retains a 49% equity interest.
- Purchase Price: Approximately $1.7 billion (subject to closing adjustments).
- Accounting Treatment: The IFP Transaction is classified as a strategic shift. Results of the IFP Business are reported as discontinued operations effective in the second quarter of fiscal 2025.
Material Changes Versus Prior Period
The primary material change is the reclassification of the IFP Business from continuing operations to discontinued operations in the 2024 Form 10-K. This affects:
- Part II, Item 7 (Management's Discussion and Analysis).
- Part II, Item 8 (Financial Statements and Supplementary Data).
- Part IV, Item 15 (Exhibits and Financial Statement Schedules).
No other revisions have been made to the 2024 Form 10-K to update for other information or events occurring since its original filing on February 13, 2025.
Guidance, Outlook, and Risks
Management Commentary: The Company states that the IFP Transaction represents a strategic shift with a major effect on operations and financial results. The filing explicitly notes that it is not an amendment or restatement of the 2024 Form 10-K but rather a recast to reflect the discontinued operations presentation.
Investor Reference: Investors are directed to read this Form 8-K in conjunction with subsequent filings, including Quarterly Reports on Form 10-Q for periods ended March 31, June 30, and September 30, 2025, for updates on risks, developments, and expectations.
Important Facts for Investor Verification
- Verify the specific impact of the $1.7 billion transaction on the 2024 fiscal year results by reviewing Exhibit 99.1 (Revisions to the 2024 Form 10-K).
- Confirm the exact closing date and final purchase price adjustments for the Suzano joint venture in subsequent filings.
- Review the Consolidated Statements of Income and Cash Flows in Exhibit 101 to see the specific line-item adjustments for discontinued operations.
- Note that the filing does not provide updated forward-looking guidance; refer to the most recent 10-Q filings for current outlook.